Grace Therapeutics (GRCE) Q1 2026 Earnings

Feb 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.28
-0.15
-0.02
0.11

Details

Expected EPS
-0.28
Actual EPS
-0.14
Surprise EPS
0.14
Surprise Percent
+50%

Description

⁨Grace Therapeutics⁩ (⁦GRCE⁩) has reported earnings of ⁦-0.14⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts